3 employees
Advancing personalized health by leveraging deep analytics and proprietary technology to decode the epigenome ("the living genome").
2013
Epinomics raised undisclosed on January 1, 2017
Investors: Hemi Ventures
Epinomics raised undisclosed on March 17, 2014
Investors: Founders Fund, Felicis Ventures, SV Angel, Lightspeed Venture Partners, DHVC, Techammer and S28 Capital